Investors in Ar

Endeit Capital is a seasoned growth capital firm dedicated to fueling internationalization and fostering innovation within the European tech sector. Since our inception in Amsterdam in 2006, we have diligently supported European tech scale-ups across various industries. With a footprint now spanning three offices across Europe and bolstered by partnerships with 72 visionary entrepreneurs, Endeit Capital boasts a robust portfolio driving technological advancements. At Endeit Capital, we are driven by a profound belief in the transformative power of technology, particularly in AI, machine learning, deep learning, and algorithms. This conviction propels our mission to empower visionary entrepreneurs who are shaping the future.

MIF II, founded in 2015 by Schiphol, KLM, TU Delft, NS, and Port of Amsterdam in collaboration with @NBI Investors, represents a strategic partnership aimed at accelerating entrepreneurial ventures. Combining Venture Capital funding with the specialized expertise and expansive global network of its founding partners, MIF II supports innovative initiatives in Logistics, Transport, and Innovation. Building on the success of Mainport Innovation Fund I, which closed in 2015 after ten impactful investments, MIF II focuses on advancing sustainable infrastructure, connectivity, mobility solutions, intermodal transport, energy innovations, digitization, IoT applications, security and safety enhancements, seamless travel experiences, and big data analytics. By nurturing pioneering technologies and business models, MIF II aims to drive transformative change and shape the future of these critical sectors.

MedSciences Capital (MSC) is a dedicated venture capital provider focused on supporting early- and mid-stage companies at the forefront of developing innovative products in the healthcare and life sciences sectors. With a mission to drive advancements in medical technologies and healthcare solutions, MedSciences Capital strategically invests in companies poised to make significant impacts on patient care and industry standards. Their investment approach combines financial support with strategic guidance and operational expertise, helping entrepreneurs navigate challenges and scale their innovations effectively. MSC's portfolio spans a wide range of healthcare innovations, including medical devices, biotechnology advancements, pharmaceuticals, and digital health solutions. By fostering partnerships and leveraging their extensive network, MedSciences Capital plays a crucial role in accelerating the development and commercialization of groundbreaking healthcare technologies that address global health challenges.

MMVentures is a Netherlands-based investment firm specializing in supporting startups and scale-ups with high growth potential. With a focus on early-stage ventures, MMVentures plays a crucial role in nurturing promising companies through strategic investments and operational support. Their approach involves identifying innovative business models and technologies across various sectors, including technology, healthcare, and sustainability. By leveraging their expertise and network, MMVentures aims to fuel entrepreneurial success and drive impactful growth in the startup ecosystem. Their commitment to partnering with ambitious founders underscores their role in facilitating innovation and economic development

Noaber focuses on driving transformative change aimed at enhancing health outcomes. Their mission emphasizes improving both health and the quality of care through strategic programs and investments. By actively participating in initiatives and partnerships, Noaber aims to maximize impact across healthcare systems, focusing on improving patient experiences, enhancing healthcare professional satisfaction, and ultimately reducing overall care costs—a concept known as the quadruple aim in healthcare management.

Peak is a prominent venture capital firm specializing in early-stage investments in SaaS, marketplaces, and platforms throughout Europe. Founded by entrepreneurs with a fund size of €125 million, Peak has successfully supported over 50 investments. Operating from offices in Amsterdam, Berlin, and Stockholm, the firm is strategically positioned to identify and nurture exceptional teams poised for growth. Peak distinguishes itself through a blend of intuitive decision-making and rigorous data analysis, enabling them to effectively guide portfolio companies through critical stages of expansion. Committed to driving innovation and market leadership, Peak partners closely with founders to capitalize on emerging opportunities and achieve sustainable success in dynamic tech markets.

Granpool Innovative Investments is a trusted partner for entrepreneurs, dedicated to fostering innovation and growth in early-stage companies. With a focus on cutting-edge technologies and disruptive business models, Granpool provides essential capital and strategic support to startups across various industries. Their investment approach is characterized by a deep commitment to collaboration, working closely with founders to navigate challenges and seize opportunities. By leveraging their extensive network and expertise, Granpool empowers entrepreneurs to scale their businesses and achieve long-term success. The firm's dedication to driving impactful change ensures that their portfolio companies are well-positioned to lead in their respective markets, contributing to a more dynamic and forward-thinking business landscape. Through active partnership and unwavering support, Granpool Innovative Investments helps shape the future of innovation.

Eyos Capital distinguishes itself as a proactive investment fund specializing in early-stage technology ventures characterized by robust intellectual property. With a hands-on approach, Eyos Capital actively supports promising companies poised for growth and innovation. Their investment strategy centers on identifying and nurturing startups with defensible technological advantages, aiming to position them as leaders in their respective fields. Eyos Capital's portfolio reflects their commitment to fostering entrepreneurial success through strategic guidance and operational support. By leveraging their expertise and network, Eyos Capital plays a pivotal role in accelerating the development and market entry of disruptive technologies, contributing to the evolution of the global tech landscape.

First Degree Capital specializes in investing in pioneering AI and innovative B2B solutions that are reshaping the future of work. With a strategic focus on cutting-edge technologies, First Degree Capital identifies and supports startups at the forefront of industry transformation. By providing crucial capital and strategic resources, they empower visionary entrepreneurs to scale their businesses and drive meaningful impact in the workplace ecosystem. Focused on the convergence of AI and B2B innovation, First Degree Capital plays a pivotal role in accelerating the adoption of disruptive technologies that enhance productivity, efficiency, and competitiveness across various sectors. Their investment philosophy centers on fostering innovation and supporting companies poised to redefine how businesses operate in the digital age. Through active partnership and dedicated support, First Degree Capital contributes to advancing the frontier of work, ensuring that their portfolio companies lead in creating solutions that meet the evolving demands of the global market.

The Future Food Fund is an early-stage venture capital impact fund focused on investing in food and agriculture companies in North West Europe. Their primary objective is to support and accelerate the transition towards sustainable food systems. By investing in innovative startups in the food and agriculture sectors, the Future Food Fund aims to drive positive environmental and social impact while fostering economic growth. The fund targets companies that are developing groundbreaking solutions to enhance sustainability, reduce waste, and improve efficiency in food production and distribution. By providing essential capital and strategic support, the Future Food Fund empowers entrepreneurs to create scalable and impactful solutions that address the pressing challenges facing the global food system. Through their investments, they are committed to promoting a more sustainable and resilient food ecosystem for future generations.

Boundary Capital Partners LLP is a venture capital firm specializing in early-stage growth companies, primarily within the technology sector. By offering both financial investment and hands-on support, Boundary Capital Partners helps innovative tech startups achieve their growth potential. Their investment approach combines capital with strategic guidance, leveraging their expertise and network to drive business success. Committed to fostering technological advancement, Boundary Capital Partners partners with visionary entrepreneurs to build the next generation of market-leading companies.

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses. Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies. By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market. Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally.